Snowball logo
logo
KPTI_logo

Karyopharm Therapeutics Inc

$4.36+$0.05Β  (1.16%)
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Karyopharm Therapeutics Inc (KPTI) operate in?

Karyopharm Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Karyopharm Therapeutics Inc (KPTI) current stock price?

As of the latest data, Karyopharm Therapeutics Inc stock price is $4.36, with a previous close of $4.31. Karyopharm Therapeutics Inc gained $0.05 in the last trading session, representing a 1.16% increase.

What is Karyopharm Therapeutics Inc (KPTI) current market capitalization?

Karyopharm Therapeutics Inc market cap is approximately 37.67 million.

What is Karyopharm Therapeutics Inc (KPTI) Earnings Per Share (EPS)?

The trailing EPS is -$11.87, and the forward EPS is -$3.03.

What is Karyopharm Therapeutics Inc (KPTI) EBITDA?

Karyopharm Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -33.26 million.

Does Karyopharm Therapeutics Inc (KPTI) pay dividends?

No. Karyopharm Therapeutics Inc does not pay a dividend.

How did Karyopharm Therapeutics Inc (KPTI) perform in its most recent earnings report?

In the last report (March 31, 2025), Karyopharm Therapeutics Inc posted an EPS surprise of 10.32% and a revenue surprise of -14.54%.

What is Karyopharm Therapeutics Inc (KPTI) beta (volatility) score?

Karyopharm Therapeutics Inc has a beta of 0.229, indicating lower volatility than the overall market.